Navigation Links
ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
Date:10/15/2007

Gift to Support Digestive Health Awareness and Clinical Research

of the American College of Gastroenterology

PHILADELPHIA, Oct. 15 /PRNewswire-USNewswire/ -- The American College of Gastroenterology and its Institute for Clinical Research & Education today announced a commitment of $1 million over four years by Salix Pharmaceuticals, Inc. The Salix pledge is an important milestone in the ACG's Advancing Excellence campaign to provide long-term support for the Institute's mission of innovative clinical research, patient education and gastroenterology practice excellence.

"This generous gift from one of our specialty's innovative newcomers boosts an impressive fundraising effort that so far has resulted in more than $16 million to support clinical research, as well as patient and physician education. The College is proud of the unprecedented support for the Institute and its mission. We recognize the generosity and commitment of Salix's leadership, including Carolyn Logan, President and CEO," said ACG President Dr. David A. Johnson.

From the campaign's beginning in 2002, the ACG Institute set an ambitious goal. From a position of burgeoning financial strength, the Institute has been able to achieve a significant boost in its support for patient-oriented research and to expand its educational programming.

About the American College of Gastroenterology

The ACG was formed in 1932 to advance the scientific study and medical treatment of disorders of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the needs of clinical gastroenterology practitioners.

About the ACG Institute for Clinical Research & Education

The ACG Institute's primary mission is to advance the field of clinical gastroenterology through education and research. Consistent with that mission, the ACG Institute for Clinical Research & Education serves as a forum in which to build on the goals of the College. The Institute promotes research in clinical gastroenterology, educates physicians and the public, and provides resources to support the future needs of clinical gastroenterology, GI patients, as well as young clinical investigators who as they develop careers in academic gastroenterology, enrich knowledge and treatments in digestive diseases.

Founded in 1994, the ACG Institute for Clinical Research & Education has emerged as a major source of funding for patient care oriented gastroenterology research, and an active and effective sponsor of educational programming for consumers and physicians alike.

About Salix

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's 150-member gastroenterology specialty sales and marketing team.


'/>"/>
SOURCE American College of Gastroenterology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... In ... researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform ... surgery, though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a leading provider ... JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. McCarter, formerly ... Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, brings 30 ...
(Date:7/20/2017)... (PRWEB) , ... July 20, ... ... provider of enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, ... world’s largest healthcare services providers. , According to Peter Ohrenberger, sales director ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... , July 21, 2017 Did you know that PhRMA ... 2016? Or that combined spending on brand medicines, generics and the ... with brands accounting for just half of this (7 percent)? Or ... thirds of the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/19/2017)... RALEIGH, N.C. , July 19, 2017  Mako ... Veteran Affairs, and the Military Family Assistance Fund (MFA) ... Louisiana to visit with their families one ... the funding to coordinate the travel and logistics needed ... supporting our deployed soldiers and their families. We just ...
(Date:7/15/2017)... , July 15, 2017 Enterin Inc., a ... treat Parkinson,s disease (PD), today announced the completion of a ... investors New Ventures III, as well as the participation of ... absolutely thrilled to have the support of New Ventures III ... investors as validation of the potential of our platform technology ...
Breaking Medicine Technology: